Cardlytics Working Capital vs Profit Margin Analysis

CDLX Stock

USD 12.58 0.36 2.95%

Cardlytics financial indicator trend analysis is way more than just evaluating Cardlytics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardlytics is a good investment. Please check the relationship between Cardlytics Working Capital and its Net Profit Margin accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Working Capital vs Net Profit Margin

Working Capital vs Profit Margin Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardlytics Working Capital account and Profit Margin. At this time, the significance of the direction appears to have no relationship.

The correlation between Cardlytics' Working Capital and Profit Margin is 0.0. Overlapping area represents the amount of variation of Working Capital that can explain the historical movement of Profit Margin in the same time period over historical financial statements of Cardlytics, assuming nothing else is changed. The correlation between historical values of Cardlytics' Working Capital and Profit Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Working Capital of Cardlytics are associated (or correlated) with its Profit Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Profit Margin has no effect on the direction of Working Capital i.e., Cardlytics' Working Capital and Profit Margin go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Working Capital

The difference between a company’s current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Net Profit Margin

The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.

Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Tax Provision is likely to rise to 0.00 in 2024, whereas Selling General Administrative is likely to drop slightly above 48.4 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	35.7M	43.7M	29.5M	16.8M
Interest Income	297K	1.4M	3.8M	3.4M

Depreciation And Amortization Interest Income

Cardlytics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets
Total Assets		0.77	0.97	0.96	0.95	0.69	0.32	0.68	0.91	0.11	-0.62	0.16	0.75	0.97	-0.33	-0.19	0.77	0.75	0.86	0.84	-0.54	0.71	0.32	0.82	-0.21	0.87
Short Long Term Debt Total	0.77		0.76	0.73	0.64	0.2	0.52	0.5	0.69	0.46	-0.81	0.07	0.64	0.7	-0.31	-0.06	1.0	0.64	0.85	0.87	-0.63	0.93	0.58	0.82	-0.21	0.76
Other Current Liab	0.97	0.76		0.99	0.9	0.62	0.33	0.55	0.92	0.22	-0.68	0.23	0.63	0.98	-0.36	-0.32	0.76	0.63	0.87	0.84	-0.5	0.71	0.33	0.83	-0.23	0.86
Total Current Liabilities	0.96	0.73	0.99		0.87	0.64	0.27	0.52	0.93	0.21	-0.64	0.35	0.6	0.98	-0.45	-0.41	0.71	0.6	0.82	0.78	-0.39	0.66	0.34	0.79	-0.29	0.81
Total Stockholder Equity	0.95	0.64	0.9	0.87		0.66	0.43	0.77	0.84	-0.08	-0.54	0.0	0.8	0.88	-0.21	-0.06	0.64	0.8	0.85	0.81	-0.58	0.6	0.02	0.79	-0.15	0.91
Other Liab	0.69	0.2	0.62	0.64	0.66		-0.38	0.42	0.62	-0.24	0.05	0.23	0.39	0.76	-0.08	-0.14	0.19	0.39	0.28	0.25	-0.18	0.12	0.25	0.24	0.01	0.34
Net Tangible Assets	0.32	0.52	0.33	0.27	0.43	-0.38		0.42	0.27	0.25	-0.76	-0.35	0.49	0.16	-0.07	0.15	0.54	0.49	0.71	0.71	-0.55	0.62	-0.25	0.72	-0.09	0.7
Property Plant And Equipment Net	0.68	0.5	0.55	0.52	0.77	0.42	0.42		0.43	-0.39	-0.28	-0.23	0.98	0.51	-0.25	0.27	0.49	0.98	0.59	0.58	-0.42	0.47	-0.04	0.52	-0.28	0.69
Current Deferred Revenue	0.91	0.69	0.92	0.93	0.84	0.62	0.27	0.43		0.27	-0.65	0.36	0.5	0.94	-0.44	-0.48	0.69	0.5	0.82	0.77	-0.41	0.63	0.31	0.8	-0.35	0.75
Net Debt	0.11	0.46	0.22	0.21	-0.08	-0.24	0.25	-0.39	0.27		-0.69	0.29	-0.27	0.2	-0.18	-0.44	0.47	-0.27	0.28	0.3	-0.17	0.61	0.56	0.47	-0.03	0.1
Retained Earnings	-0.62	-0.81	-0.68	-0.64	-0.54	0.05	-0.76	-0.28	-0.65	-0.69		-0.04	-0.41	-0.58	0.28	0.24	-0.83	-0.41	-0.85	-0.87	0.57	-0.91	-0.33	-0.94	0.16	-0.75
Accounts Payable	0.16	0.07	0.23	0.35	0.0	0.23	-0.35	-0.23	0.36	0.29	-0.04		-0.24	0.31	-0.75	-0.86	0.0	-0.24	-0.08	-0.1	0.63	-0.03	0.34	0.03	-0.48	-0.19
Cash	0.75	0.64	0.63	0.6	0.8	0.39	0.49	0.98	0.5	-0.27	-0.41	-0.24		0.57	-0.24	0.27	0.64	1.0	0.7	0.71	-0.53	0.6	0.08	0.62	-0.25	0.78
Non Current Assets Total	0.97	0.7	0.98	0.98	0.88	0.76	0.16	0.51	0.94	0.2	-0.58	0.31	0.57		-0.35	-0.35	0.69	0.57	0.78	0.75	-0.44	0.64	0.39	0.76	-0.19	0.77
Non Currrent Assets Other	-0.33	-0.31	-0.36	-0.45	-0.21	-0.08	-0.07	-0.25	-0.44	-0.18	0.28	-0.75	-0.24	-0.35		0.76	-0.24	-0.24	-0.21	-0.18	-0.44	-0.26	-0.29	-0.3	0.89	-0.13
Other Assets	-0.19	-0.06	-0.32	-0.41	-0.06	-0.14	0.15	0.27	-0.48	-0.44	0.24	-0.86	0.27	-0.35	0.76		-0.01	0.27	-0.07	-0.02	-0.48	-0.07	-0.23	-0.21	0.62	0.04
Long Term Debt	0.77	1.0	0.76	0.71	0.64	0.19	0.54	0.49	0.69	0.47	-0.83	0.0	0.64	0.69	-0.24	-0.01		0.64	0.87	0.89	-0.69	0.93	0.55	0.83	-0.16	0.78
Cash And Short Term Investments	0.75	0.64	0.63	0.6	0.8	0.39	0.49	0.98	0.5	-0.27	-0.41	-0.24	1.0	0.57	-0.24	0.27	0.64		0.7	0.71	-0.53	0.6	0.08	0.62	-0.25	0.78
Net Receivables	0.86	0.85	0.87	0.82	0.85	0.28	0.71	0.59	0.82	0.28	-0.85	-0.08	0.7	0.78	-0.21	-0.07	0.87	0.7		0.99	-0.73	0.83	0.19	0.94	-0.15	0.97
Common Stock Shares Outstanding	0.84	0.87	0.84	0.78	0.81	0.25	0.71	0.58	0.77	0.3	-0.87	-0.1	0.71	0.75	-0.18	-0.02	0.89	0.71	0.99		-0.73	0.85	0.24	0.93	-0.1	0.94
Short Term Investments	-0.54	-0.63	-0.5	-0.39	-0.58	-0.18	-0.55	-0.42	-0.41	-0.17	0.57	0.63	-0.53	-0.44	-0.44	-0.48	-0.69	-0.53	-0.73	-0.73		-0.65	-0.1	-0.63	-0.32	-0.74
Long Term Debt Total	0.71	0.93	0.71	0.66	0.6	0.12	0.62	0.47	0.63	0.61	-0.91	-0.03	0.6	0.64	-0.26	-0.07	0.93	0.6	0.83	0.85	-0.65		0.53	0.9	-0.16	0.74
Non Current Liabilities Total	0.32	0.58	0.33	0.34	0.02	0.25	-0.25	-0.04	0.31	0.56	-0.33	0.34	0.08	0.39	-0.29	-0.23	0.55	0.08	0.19	0.24	-0.1	0.53		0.23	-0.15	0.03
Capital Surpluse	0.82	0.82	0.83	0.79	0.79	0.24	0.72	0.52	0.8	0.47	-0.94	0.03	0.62	0.76	-0.3	-0.21	0.83	0.62	0.94	0.93	-0.63	0.9	0.23		-0.18	0.89
Inventory	-0.21	-0.21	-0.23	-0.29	-0.15	0.01	-0.09	-0.28	-0.35	-0.03	0.16	-0.48	-0.25	-0.19	0.89	0.62	-0.16	-0.25	-0.15	-0.1	-0.32	-0.16	-0.15	-0.18		-0.1
Other Current Assets	0.87	0.76	0.86	0.81	0.91	0.34	0.7	0.69	0.75	0.1	-0.75	-0.19	0.78	0.77	-0.13	0.04	0.78	0.78	0.97	0.94	-0.74	0.74	0.03	0.89	-0.1

Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	224.3M	422.5M	1.3B	691.2M	574.1M	440.0M
Short Long Term Debt Total	37K	188.1M	197.2M	235.3M	266.1M	138.7M
Other Current Liab	76.0M	74.8M	313.4M	238.5M	162.2M	126.0M
Total Current Liabilities	78.4M	81.3M	327.4M	248.9M	171.1M	135.4M
Total Stockholder Equity	143.3M	157.2M	690.7M	211.6M	134.8M	98.0M
Other Liab	2.6M	679K	54.5M	334K	384.1K	364.9K
Net Tangible Assets	139.1M	150.4M	(190.5M)	158.1M	181.8M	190.9M
Property Plant And Equipment Net	14.3M	24.6M	21.5M	12.5M	10.6M	14.5M
Current Deferred Revenue	1.1M	349K	3.3M	1.8M	2.4M	1.3M
Net Debt	(104.4M)	(105.1M)	(36.2M)	113.4M	174.3M	183.0M
Retained Earnings	(338.6M)	(394.1M)	(522.6M)	(976.6M)	(1.1B)	(1.1B)
Accounts Payable	1.2M	1.4M	4.6M	3.8M	4.4M	3.2M
Cash	104.5M	293.2M	233.5M	121.9M	91.8M	116.8M
Non Current Assets Total	28.6M	36.9M	905.1M	441.2M	350.2M	226.1M
Non Currrent Assets Other	10.1M	5.6M	2.4M	2.6M	2.7M	2.6M
Other Assets	10.1M	22.6M	2.4M	2.6M	2.3M	2.2M
Long Term Debt	13K	174.0M	184.4M	226.0M	257.6M	130.8M
Cash And Short Term Investments	104.5M	293.2M	233.5M	121.9M	91.8M	116.8M
Net Receivables	85.4M	86.6M	117.2M	120.1M	126.0M	89.2M
Common Stock Shares Outstanding	23.7M	27.2M	32.2M	33.4M	36.5M	26.9M
Long Term Debt Total	13K	174.0M	184.4M	226.0M	260.0M	273.0M
Liabilities And Stockholders Equity	224.3M	422.5M	1.3B	691.2M	574.1M	440.0M
Non Current Liabilities Total	2.6M	184.1M	245.7M	230.7M	268.2M	206.5M
Capital Surpluse	480.6M	551.4M	1.2B	1.2B	1.4B	1.4B
Inventory	129K	110K	95K	80K	72K	68.4K
Other Current Assets	5.8M	5.7M	8.0M	8.0M	6.1M	5.2M
Other Stockholder Equity	480.6M	551.4M	1.2B	1.2B	1.2B	628.4M
Total Liab	81.0M	265.3M	573.1M	479.6M	439.3M	342.0M
Deferred Long Term Liab	8.5M	3.8M	139K	198K	178.2K	169.3K
Property Plant And Equipment Gross	14.3M	24.6M	11.3M	5.9M	43.7M	45.9M
Total Current Assets	195.7M	385.6M	358.7M	250.0M	223.9M	213.8M
Accumulated Other Comprehensive Income	1.3M	(192K)	486K	5.6M	2.5M	1.9M
Short Term Debt	24K	4.7M	6.0M	4.9M	2.1M	3.6M
Intangible Assets	4.2M	6.7M	138.7M	73.4M	59.6M	35.1M
Property Plant Equipment	14.3M	13.9M	21.5M	5.9M	6.8M	12.5M

Pair Trading with Cardlytics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.

The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:

How To Invest In Cardlytics

Details

Is Cardlytics Stock a good investment?

Details

What is Cardlytics' Net Worth?

Details

Largest Advertising Companies

View

Largest Media & Entertainment Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Cardlytics Stock analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.

	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets

Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.57)

Earnings Share

(3.69)

Revenue Per Share

8.474

Quarterly Revenue Growth

0.081

Return On Assets

(0.06)

The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardlytics Working Capital vs Profit Margin Analysis

Working Capital vs Net Profit Margin

Working Capital vs Profit Margin Correlation Analysis

Correlation Coefficient

Working Capital

Net Profit Margin

Cardlytics fundamental ratios Correlations

Cardlytics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cardlytics fundamental ratios Accounts

Pair Trading with Cardlytics

Complementary Tools for Cardlytics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Current Liabilities	+ 0.99	Other Current Liab
Common Stock Shares Outstanding	+ 0.99	Net Receivables
Non Current Assets Total	+ 0.98	Other Current Liab
Non Current Assets Total	+ 0.98	Total Current Liabilities

Capital Surpluse	- 0.94	Retained Earnings
Long Term Debt Total	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.87	Retained Earnings
Other Assets	- 0.86	Accounts Payable
Net Receivables	- 0.85	Retained Earnings
Long Term Debt	- 0.83	Retained Earnings